Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.

(15th September 2003, Cambridge, UK) BioWisdom are pleased to announce a non-exclusive license agreement with GlaxoSmithKline (GSK), to provide elements of their biomedical ontology.

An ontology is a specialized form of knowledgebase that describes the relationships that exist between concepts in a particular domain. Examples of ontology concepts relevant to pharmaceutical R&D include diseases, genes and proteins, tissues and cells, drugs and chemicals. Under this agreement, BioWisdom will provide an ontology covering the classification of the human proteins that are of greatest interest for drug discovery. Synonyms, labeled for ambiguity as appropriate, are included in the ontology, making it particularly useful for information retrieval engines to enhance the quality of searching.

The ontology has been provided under a license agreement. Under the terms of the agreement, GSK have rights to use the ontology across a number of internal applications relevant to R&D. They will also receive quarterly updates from BioWisdom, to ensure the ontology remains current.

Gordon Smith Baxter, CEO of BioWisdom, commenting on the agreement said, "We are very pleased to be able to extend our collaboration with GSK. The provision of ontology directly to pharmaceutical companies is one of BioWisdom’s core offerings and part of our aim to promote the use of ontologies in pharmaceutical R&D.”

About BioWisdom Ltd
BioWisdom Ltd., headquartered in Cambridge UK, and established in September 2000, is a world leader in Ontology, a branch of science that seeks to improve access to information and enhance communication between people. The company focuses on pharmaceutical R&D, where it's technology is used in a wide variety of applications, relevant to the discovery and development of novel drug therapies.

For further information, please contact:

Gordon Smith Baxter, CEOBioWisdom LtdTel: +44 (0)1223 492100Email: gordon.baxter@biowisdom.comhttp://www.biowisdom.com

This press release was distributed by ResponseSource Press Release Wire on behalf of BioWisdom Ltd in the following categories: Consumer Technology, Personal Finance, Business & Finance, Computing & Telecoms, for more information visit https://pressreleasewire.responsesource.com/about.